Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD

NCT02736695 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT02736695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02736695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and FTD
Lead sponsor
Mayo Clinic
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2016
Completion date
August 1, 2024
Enrollment
81 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behavioral variant of frontotemporal dementia, frontotemporal dementia, behavioral variant, primary progressive aphasia